This site is intended only for healthcare professionals resident in the Republic of Ireland




Sign in or registerLog out
Our medicinesTherapy areasExplore contentExplore contentMaterialsVideosPodcastsLet’s connectLet's connectContact usSign up



About NSCLCPortfolio
Non-Small-Cell Lung Cancer (NSCLC)

Lung cancer continous to be a leading cause of cancer mortality worldwide,1 impacting millions of people around the world. For patients diagnosed between 2012 and 2018 with NSCLC with distant metastases (SEER Stage), the 5-year survival rate was only 9%,2 highlighting the importance of early diagnosis, optimized treatment options and successful management of adverse events to improve patients' quality of life. Find out more about the recent advances in this field and what you can do to improve outcomes for your patients.

About NSCLC Investigate the biology and subtypes of NSCLC. Find out more Loading PortfolioLearn more about Pfizer's treatment options for NSCLC. Discover more Loading
AbbreviationsNSCLC, non-small-cell lung cancer.ReferencesInternational Agency for Research on Cancer WHO.Source Globocan 2020. Accessed July 2023.Lung cancer survival rates: 5-year survival rates for lung cancer | American Cancer Society. Available at: (Accessed: July 2023).
PP-LOR-IRL-0104 Date of preparation February 2024 Further information available on request

Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)

Adverse events should also be reported to Pfizer Medical Information on 1800 633 363

PfizerPro AccountPfizerPro Account

Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.

Sign in or RegisterRegisterAccountLog out

This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.


Copyright © 2024 Pfizer Limited. All rights reserved.

PP-UNP-IRL-0733. March 2024
You are now leaving PfizerPro
You are now leaving PfizerPro Ireland. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer. Pfizer accepts no responsibility for the content or services of the linked site.

PP-UNP-IRL-0733. March 2024
For Healthcare Professionals in the Republic of Ireland *

The information on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland and contains promotional content.

I confirm that I am a healthcare professional* resident in the Republic of Ireland.

If you select 'No', you will be redirected to, where you will be able to access information on Pfizer Healthcare Ireland.

*The IPHA Code definition of a healthcare profressional is a person of any of the following classes: (i) Registered medical practitioners (ii) Registered dentists (iii) Registered pharmacists (iv) Registered nurses

Terms of use

PP-UNP-IRL-0733 . March 2024

Yes No